Cvs Health CORP 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
CVS Health reports a 7.8% revenue increase in 2025 to $402.07 billion, driven by growth across all segments, despite a significant goodwill impairment charge and increased litigation expenses impacting net income.
NYSE
CVS Health Corporation releases its 10-K filing for fiscal year 2024, detailing financial performance and strategic initiatives amidst a changing healthcare industry.
NYSE
CVS Health Corporation's recent 10-K filing provides a detailed description of its common stock, authorized capital, and compliance with securities regulations.